Axsome Therapeutics's total assets for Q3 2024 were $561.46M, an increase of 2.41% from the previous quarter. AXSM total liabilities were $468.56M for the fiscal quarter, a 5.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.